{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:22:07Z","timestamp":1789078927882,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jss.2022.04.012","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:47:53Z","timestamp":1652730473000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?"],"prefix":"10.1016","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-7159","authenticated-orcid":false,"given":"Erin A.","family":"Strong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-2668","authenticated-orcid":false,"given":"Austin","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Gracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Clark","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-2848","authenticated-orcid":false,"given":"Karen","family":"Kersting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callisia N.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2022.04.012_bib1","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2022.04.012_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","article-title":"Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome","volume":"27","author":"Chua","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jss.2022.04.012_bib3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib4","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ejso.2018.10.086","article-title":"A UNICANCER phase III trial of hyperthermic Intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. PRODIGE 7","volume":"45","author":"Quenet","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib5","unstructured":"Dunn G.P. Surgical palliative care: a resident\u2019s guide. Available at: https:\/\/www.facs.org\/media\/vzfpkv4h\/surgicalpalliativecareresidents.pdf. Accessed June 1, 2021."},{"key":"10.1016\/j.jss.2022.04.012_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1200\/JCO.2011.38.5161","article-title":"American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.soc.2018.02.008","article-title":"Palliative management of advanced peritoneal carcinomatosis","volume":"27","author":"Lambert","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.jss.2022.04.012_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","article-title":"Malignant ascites: a review of prognostic factors, pathophysiology and therapeutic measures","volume":"4","author":"Sangisetty","year":"2012","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.jss.2022.04.012_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.25453","article-title":"Palliation of malignant ascites","volume":"120","author":"Hodge","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib10","doi-asserted-by":"crossref","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jss.2022.04.012_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2022.04.012_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1457496915598759","article-title":"Palliative surgery for pseudomyxoma peritonei","volume":"105","author":"Funder","year":"2016","journal-title":"Scand J Surg"},{"key":"10.1016\/j.jss.2022.04.012_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jamasurg.2013.4059","article-title":"Palliative surgery for malignant bowel obstruction from carcinomatosis a systematic review","volume":"149","author":"Olson","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jss.2022.04.012_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jso.23707","article-title":"Surgical management of bowel obstruction in patients with peritoneal carcinomatosis","volume":"110","author":"Shariat-Madar","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib16","first-page":"4293","article-title":"The role of \u201cclosed abdomen\u201d hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience","volume":"24","author":"Orgiano","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jss.2022.04.012_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijsu.2015.09.074","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery","volume":"23","author":"Valle","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.jss.2022.04.012_bib18","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-012-2360-0","article-title":"Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature","volume":"19","author":"Facchiano","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jss.2016.11.066","article-title":"Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"211","author":"Morris","year":"2017","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2022.04.012_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1245\/s10434-017-6326-0","article-title":"Long-term quality of life after cytoreductive surgery and heated intraperitoneal chemotherapy for pseudomyxoma peritonei: a prospective longitudinal study","volume":"25","author":"Stearns","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jso.23089","article-title":"Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS+HIPEC)","volume":"106","author":"Duckworth","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.04.012_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s13063-019-3754-0","article-title":"A randomized trial of a specialist palliative care intervention for patients undergoing surgery for cancer: rationale and design of the Surgery for Cancer with Option of Palliative Care Expert (SCOPE)","volume":"20","author":"Shinall","year":"2019","journal-title":"Trial"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:57:49Z","timestamp":1758380269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480422001949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"alternative-id":["S0022480422001949"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2022.04.012","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2022.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}